20-Jul-2011 - Clinical trials of a monoclonal antibody produced in transgenic tobacco plants, a potentially low-cost, scalable system, have begun in Europe.
13-Jul-2011 - The FDA is offering a grant to research projects that improve the reliability, speed and quality of biopharm production processes.
11-Jul-2011 - Developments in the field of Chinese Hamster Ovary (CHO) based biomanufacturing this week with new products from SAFC and BD Biosciences.
05-Jul-2011 - Shire has received European Medicines Agency (EMA) approval for a new US plant, doubling purification capacity for its Fabry disease drug Replagal.
30-Jun-2011 - Prosonix has secured funding to move its pipeline of proprietary mono and multi-component combination respiratory therapies through clinical development.
20-Jun-2011 - Dr Reddy's Mexican API production plant has received an FDA warning letter that details failures to validate analytical methods and other problems.
14-Jun-2011 - Sartorius Stedim Biotech (SSB) has teamed up with packaging firm Sudpack Medica AG in a deal focused on making plastic films for biopharmaceutical industry applications.
13-Jun-2011 - Sales to the biopharmaceutical sector drove revenue growth at Pall in third quarter fiscal 2011 and will be key to the firm’s future says CEO.
13-Jun-2011 - Symetic has opened a new lab facility to showcase its range of processing systems to the pharmaceutical manufacturing, packaging and nutraceutical sectors.
09-Jun-2011 - Portugal-headquartered API manufacturer Hovione has teamed up with Particle Sciences (PSI) to tackle the issue of poor drug solubility.
07-Jun-2011 - Analytical technology firm Avacta says it has won its first top ten US pharma customer in collaboration with marketing partner Pall Life Sciences.
06-Jun-2011 - Biomanufacturing technology firm Xcellerex has had a good start to June with R-Pharm and Fujifilm Diosynth signing up as customers.
16-May-2011 - Californian Bioreactor manufacturer, PBS Biotech, has launched its new PBS 3 single-use bioreactor system for the development of biological therapeutics, vaccines and biosimilars.
12-May-2011 - Sartorius Stedim Biotech (SSB) has launched a new small-scale bioreactor citing growing biopharmaceutical company demand for scale-up technologies as the key driver for its development.
05-May-2011 - Aptuit is manufacturing Phase III materials for Iroko using a nanoformulation technology that produces fast-dissolving particles.
04-May-2011 - Prosonix and Italian partner Sterling have completed the commercialisation of a respiratory active pharmaceutical ingredient (API) using the UK firm’s unique particle engineering technology.
03-May-2011 - in-PharmaTechnologist presents a round up of biopharm manufacturing expansions, including details of new plants for OmniLytics and Morphotek.
02-May-2011 - Scientists at Eindhoven’s University of Technology (TU/e) say their new ‘spinning disc reactor’ increases the safety and efficiency of chemical production processes.
26-Apr-2011 - Bio-Rad has launched what it claims is the drug industry’s first all in one chromatrography platform for small-scale biopharmaceutical manufacturing.
21-Apr-2011 - Industrial PC supplier Noax says pharmaceutical industry demand for sealed computers is growing and being driven by increasing regulatory focus on containment in manufacturing processes.
19-Apr-2011 - Continuous manufacturing offers significant advantages for drug production in terms of quality and efficiency, but more research and regulatory input is needed to help the pharmaceutical sector reap the benefits according to ISP.
18-Apr-2011 - ATMI has added process control to its single-use bioreactor through a distribution deal with Finesse Solutions.
12-Apr-2011 - How have single-use technologies changed drug production? How do you dispose of a disposable technology? What will drive the market going forward? EMD Millipore answered these questions and more at Interphex 2011.
11-Apr-2011 - PTI Inspection Systems and Nikka Densok USA have teamed up to take high-voltage leak detection (HVLD) from the factory floor to the pharmaceutical lab.
07-Apr-2011 - Embedding QbD elements into drug development could make approval timelines and inspection success more predictable, say a Genentech team.